Scarica l'app Stockscreener
100.11
0.02%
0.02
Dopo l'orario di chiusura:
100.27
0.16
+0.16%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Illumina Inc Borsa (ILMN) Ultime notizie
Carl Icahn raises shared share stake in Centuri Holdings, dissolves in Dana, Illumina - MarketScreener
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance
Now that NGS is more affordable, how can we make it easier? - Illumina
Illumina’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Illumina Settles $9.8M False Claims Case Over Vulnerable Genomic Systems - WebProNews
[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know - TradingView
Illumina Sees Future Rebound in China Sales - San Diego Business Journal
Daiwa Securities Downgrades Illumina to Neutral From Outperform, Adjusts Price Target to $94 From $124 - MarketScreener
US Personalized Medicine Market Trends and Company Analysis - GlobeNewswire
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche - Yahoo Finance
How Illumina Inc. stock performs during market volatilityMaximum Yield Stock Screener - classian.co.kr
Standard BioTools Announces SomaLogic Sale to Illumina - TipRanks
Latest Cybersecurity False Claims Act Settlement with Diagnostics Provider Focuses on Sensitive Health Systems - Inside Privacy
Illumina price leans on SMA supportForecast today11-08-2025 - Economies.com
DNA Microarray Market to Grow at 9% CAGR, Driven by Personalized - openPR.com
Single Cell Genome Sequencing Market is evolving rapidly Through 2025 To 2032 | Illumina, Inc., Fludigim Corporation - openPR.com
Is Illumina Inc. a strong growth stockEarnings Surprise Driven Picks - thegnnews.com
What makes Illumina Inc. stock price move sharplyMulti-Sector Diversified Watchlist - thegnnews.com
What are analysts’ price targets for Illumina Inc.Weekly Oversold Bounce Candidates - thegnnews.com
DOJ Settlement With Medical Technology Company Signals Expanding Cybersecurity FCA Risk for Life Sciences Companies - JD Supra
Illumina (NASDAQ:ILMN) Strong Profits May Be Masking Some Underlying Issues - simplywall.st
Illumina Settles With DOJ, Veterans to End Whistleblower Lawsuit Over Genomic Sequencing Systems with Cybersecurity Vulnerabilities - AInvest
DOJ Secures First of Its Kind Cybersecurity False Claims Act Settlement - JD Supra
Bioinformatics Market Booms with Rapid Growth Expected by 2032 | Active Motif, Inc., Illumina - openPR.com
Illumina Reaches $9.8M Deal in Cybersecurity False Claims Probe - Homeland Security Today
Illumina Stock Slides 0.69 as Mixed Analyst Reactions Highlight 490th-Ranked Volume Amid Profitability Surge and Growth Doubts - AInvest
Illumina pays $9.8 million to settle DOJ claims over cybersecurity failures in government contracts - teiss
“False” Sense of Security: DOJ Announces False Claims Act Settlements Related to Failure to Comply with Cybersecurity Requirements - JD Supra
Does Illumina (ILMN) have an Attractive Risk-Reward Opportunity for Long-Term Investors? - MSN
Illumina Inc. to Pay $9.8M to Resolve False Claims Act Allegations Arising from Cybersecurity Vulnerabilities in Genomic Sequencing Systems - Sierra Sun Times
Illumina (ILMN) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Illumina, Inc. Just Recorded A 76% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
DOJ reaches USD 9.8M settlement with Illumina - Medical Buyer
Genomic Systems Maker Settles Cybersecurity Lawsuit - Manufacturing Business Technology
DOJ reaches $9.8M settlement with Illumina over cyber whistleblower claims - MedTech Dive
Unexpected Trends Reshaping the U.S. Genomics Market by 2032 - openPR.com
Insider Buying Surges at BEEX Holdings: Chubb and Illumina Lead the Way - AInvest
How the U.S. Precision Medicine Market Will Evolve by 2032 - openPR.com
Illumina’s SomaLogic acquisition may face GRAIL-like regulatory hurdles - ION Analytics
Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued? - au.finance.yahoo.com
Multi-Omics Market to Surpass US$33.25 Billion by 2033, Driven - openPR.com
Illumina Second Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Illumina: The Stock Is Still Undervalued (NASDAQ:ILMN) - Seeking Alpha
Illumina Settles Allegations of Cyber Vulnerabilities in Genomic Sequencing for $9.8M - Claims Journal
What catalysts could drive Illumina Inc. stock higher in 2025Capitalize on market trends with confidence - Jammu Links News
What is Illumina Inc. company’s growth strategyGame-changing returns - jammulinksnews.com
What are Illumina Inc. company’s key revenue driversSuperior stock growth - Jammu Links News
Should I hold or sell Illumina Inc. stock in 2025Extraordinary market timing - Jammu Links News
Illumina, Inc.'s (NASDAQ:ILMN) Stock Is Going Strong: Have Financials A Role To Play? - simplywall.st
How does Illumina Inc. compare to its industry peersBuild a balanced portfolio for long-term success - Jammu Links News
Published on: 2025-08-03 17:43:00 - Jammu Links News
What is the dividend policy of Illumina Inc. stockBreakthrough profits - Jammu Links News
Illumina Inc. Stock Analysis and ForecastDiscover stock picks with superior returns - Jammu Links News
How strong is Illumina Inc. company’s balance sheetInvest confidently with professional guidance - Jammu Links News
0.67%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):